Avanos Medical (AVNS) Revenue & Revenue Breakdown
Avanos Medical Revenue Highlights
Latest Revenue (Y)
$673.30M
Latest Revenue (Q)
$171.70M
Main Segment (Y)
Digestive Health
Main Geography (Y)
UNITED STATES
Avanos Medical Revenue by Period
Avanos Medical Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $673.30M | -17.89% |
| 2022-12-31 | $820.00M | 10.13% |
| 2021-12-31 | $744.60M | 4.17% |
| 2020-12-31 | $714.80M | 2.47% |
| 2019-12-31 | $697.60M | 6.94% |
| 2018-12-31 | $652.30M | 6.65% |
| 2017-12-31 | $611.60M | -61.59% |
| 2016-12-31 | $1.59B | 1.14% |
| 2015-12-31 | $1.57B | -5.84% |
| 2014-12-31 | $1.67B | -0.32% |
| 2013-12-31 | $1.68B | -0.39% |
| 2012-12-31 | $1.68B | 1.45% |
| 2011-12-31 | $1.66B | - |
Avanos Medical generated $673.30M in revenue during NA 2023, up -17.89% compared to the previous quarter, and up 103.22% compared to the same period a year ago.
Avanos Medical Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $171.70M | 3.37% |
| 2024-03-31 | $166.10M | -4.15% |
| 2023-12-31 | $173.30M | 1.17% |
| 2023-09-30 | $171.30M | 1.12% |
| 2023-06-30 | $169.40M | -11.63% |
| 2023-03-31 | $191.70M | -11.86% |
| 2022-12-31 | $217.50M | 7.62% |
| 2022-09-30 | $202.10M | -0.44% |
| 2022-06-30 | $203.00M | 2.84% |
| 2022-03-31 | $197.40M | 2.07% |
| 2021-12-31 | $193.40M | 5.05% |
| 2021-09-30 | $184.10M | -1.23% |
| 2021-06-30 | $186.40M | 3.15% |
| 2021-03-31 | $180.70M | -2.32% |
| 2020-12-31 | $185.00M | -0.38% |
| 2020-09-30 | $185.70M | 13.44% |
| 2020-06-30 | $163.70M | -9.26% |
| 2020-03-31 | $180.40M | -4.95% |
| 2019-12-31 | $189.80M | 10.74% |
| 2019-09-30 | $171.40M | -0.46% |
| 2019-06-30 | $172.20M | 4.87% |
| 2019-03-31 | $164.20M | -3.35% |
| 2018-12-31 | $169.90M | 2.91% |
| 2018-09-30 | $165.10M | 2.61% |
| 2018-06-30 | $160.90M | 2.88% |
| 2018-03-31 | $156.40M | -126.75% |
| 2017-12-31 | $-584.60M | -245.64% |
| 2017-09-30 | $401.40M | 0.55% |
| 2017-06-30 | $399.20M | 0.91% |
| 2017-03-31 | $395.60M | -3.51% |
| 2016-12-31 | $410.00M | 3.14% |
| 2016-09-30 | $397.50M | -0.63% |
| 2016-06-30 | $400.00M | 3.95% |
| 2016-03-31 | $384.80M | -4.14% |
| 2015-12-31 | $401.40M | 3.06% |
| 2015-09-30 | $389.50M | 0.05% |
| 2015-06-30 | $389.30M | -1.24% |
| 2015-03-31 | $394.20M | -10.29% |
| 2014-12-31 | $439.40M | 7.56% |
| 2014-09-30 | $408.50M | -1.21% |
| 2014-06-30 | $413.50M | 0.68% |
| 2014-03-31 | $410.70M | -4.78% |
| 2013-12-31 | $431.30M | 2.81% |
| 2013-09-30 | $419.50M | 0.87% |
| 2013-06-30 | $415.90M | 1.24% |
| 2013-03-31 | $410.80M | - |
Avanos Medical generated $171.70M in revenue during Q2 2024, up 3.37% compared to the previous quarter, and up 89.57% compared to the same period a year ago.
Avanos Medical Revenue Breakdown
Avanos Medical Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Interventional Pain | $162.50M | - | - | - | - |
| Digestive Health | $371.60M | - | - | - | - |
| Pain Management | - | $343.70M | $264.80M | $243.60M | $283.90M |
| Respiratory health | - | $135.90M | $157.60M | - | - |
| Acute pain | - | $160.10M | $162.70M | - | - |
| Chronic Care | - | $476.30M | $479.80M | $471.20M | $413.70M |
| Interventional pain | - | $183.60M | $102.10M | - | - |
| Digestive health | - | $340.40M | $322.20M | - | - |
Avanos Medical's latest annual revenue breakdown by segment (product or service), as of Dec 23: Digestive Health (69.57%), and Interventional Pain (30.43%).
Quarterly Revenue by Product
| Product/Service | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Sep 19 | Jun 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Digestive Health | $97.70M | $94.70M | $183.60M | $95.00M | $93.00M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interventional pain | $41.70M | $40.20M | $42.20M | $41.60M | $35.80M | $47.40M | $47.50M | $49.50M | $39.30M | - | - | - | - | - | - | - | - | - | - | - |
| Chronic Care | - | - | - | - | - | $121.20M | $128.80M | $115.70M | $112.30M | $119.40M | $125.60M | $117.10M | $116.00M | $121.10M | $116.00M | $119.30M | $120.20M | $115.70M | $98.00M | $102.30M |
| Acute pain | - | - | - | - | - | $34.70M | $41.30M | $38.90M | $41.20M | $38.70M | - | - | - | - | - | - | - | - | - | - |
| Digestive health | - | - | - | - | - | $88.80M | $92.90M | $85.90M | $80.20M | $81.40M | - | - | - | - | - | - | - | - | - | - |
| Pain Management | - | - | - | - | - | $70.50M | $88.70M | $86.40M | $90.70M | $78.00M | $67.80M | $67.00M | $70.40M | $59.60M | $69.00M | $66.40M | $43.50M | $64.70M | $73.40M | $69.90M |
| Respiratory health | - | - | - | - | - | $32.40M | $35.90M | $29.80M | $32.10M | $38.00M | - | - | - | - | - | - | - | - | - | - |
Avanos Medical's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Digestive Health (70.09%), and Interventional pain (29.91%).
Avanos Medical Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| UNITED STATES | $467.00M | $560.70M | $521.60M | $482.00M | $481.00M |
Avanos Medical's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (100.00%).
Avanos Medical Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ITGR | Integer | $1.60B | $753.01M |
| CNMD | CONMED | $1.24B | $332.10M |
| LIVN | LivaNova | $1.15B | $318.60M |
| AVNS | Avanos Medical | $673.30M | $171.70M |
| NVRO | Nevro | $425.17M | $101.90M |
| AORT | Artivion | $354.00M | $98.02M |
| GKOS | Glaukos | $314.71M | $95.69M |
| FNA | Paragon 28 | $216.39M | $61.02M |
| ANIK | Anika Therapeutics | $166.66M | $41.92M |
| ESTA | Establishment Labs | $165.15M | $44.12M |
| AXGN | AxoGen | $159.01M | $47.91M |
| KIDS | OrthoPediatrics | $148.73M | $52.80M |
| SRDX | Surmodics | $132.58M | $30.34M |
| SGHT | Sight Sciences | $81.06M | $21.37M |
| OFIX | Orthofix Medical | $100.00K | $198.62M |
AVNS Revenue FAQ
What is Avanos Medical’s yearly revenue?
Avanos Medical's yearly revenue for 2023 was $673.3M, representing a decrease of -17.89% compared to 2022. The company's yearly revenue for 2022 was $820M, representing an increase of 10.13% compared to 2021. AVNS's yearly revenue for 2021 was $744.6M, representing an increase of 4.17% compared to 2020.
What is Avanos Medical’s quarterly revenue?
Avanos Medical's quarterly revenue for Q2 2024 was $171.7M, a 3.37% increase from the previous quarter (Q1 2024), and a 1.36% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $166.1M, a -4.15% decrease from the previous quarter (Q4 2023), and a -13.35% decrease year-over-year (Q1 2023). AVNS's quarterly revenue for Q4 2023 was $173.3M, a 1.17% increase from the previous quarter (Q3 2023), and a -20.32% decrease year-over-year (Q4 2022).
What is Avanos Medical’s revenue growth rate?
Avanos Medical's revenue growth rate for the last 3 years (2021-2023) was -9.58%, and for the last 5 years (2019-2023) was -3.48%.
What are Avanos Medical’s revenue streams?
Avanos Medical's revenue streams in c 23 are Interventional Pain, and Digestive Health. Interventional Pain generated $162.5M in revenue, accounting 30.43% of the company's total revenue Digestive Health generated $371.6M in revenue, accounting 69.57% of the company's total revenue
What is Avanos Medical’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of Avanos Medical was Digestive Health. This segment made a revenue of $371.6M, representing 69.57% of the company's total revenue.